Bronchial thermoplasty in a patient with difficult-to-control asthma

Rubin, Adalberto Sperb; Zelmanovitz, Suzana; Cavalcanti, Manuela; Spilimbergo, Fernanda; Goldenfum, Paulo; Felicetti, José Carlos; Cardoso, Paulo Francisco Guerreiro

doi:10.1590/s1806-37562015000000044

Cited by 1 publication

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Other Add-on Therapies For Adults With Asthma Uncontrolled Wmentioning

confidence: 99%

“…Bronchial thermoplasty is a non-pharmaceutical intervention that uses thermal energy to reduce the amount of smooth muscle in the airway walls, making it less likely that the airways will become narrow in the future. 64 This option has shown improvements in quality of life and reduced exacerbations in patients with severe asthma. As it is an expensive intervention requiring several bronchoscopies, more evidence is required on the long-term efficacy and safety of the procedure to accurately assess its role and cost–benefit.…”

Section: Other Add-on Therapies For Adults With Asthma Uncontrolled Wmentioning

confidence: 99%

See 1 more Smart Citation

<p>Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies</p>

Jenkins

2019

TCRM

View full text Add to dashboard Cite

Despite the availability of a range of treatment options and management guidelines, a high proportion of adults with asthma remain uncontrolled. The challenge of managing uncontrolled asthma includes providing efficacious treatment while limiting side effects, recognizing situations when a change in asthma therapy is required, and considering patient preferences and satisfaction. In line with the Global Initiative for Asthma report, asthma management is based on a backbone of inhaled corticosteroid (ICS) therapy and use of add-on therapies to achieve disease control. This review considers whether add-on options could be better utilized in clinical practice. A number of long-acting muscarinic antagonists are in development, but tiotropium is the most widely studied for use in asthma. Evidence demonstrating the efficacy of tiotropium as an add-on therapy to at least ICS in adults with symptomatic mild, moderate, and severe asthma is presented from randomized controlled trials and real-world evidence. In addition, the benefit of tiotropium therapy in a wide range of patient phenotypes and disease severities without the need for biomarker assessment is discussed. Additional strategies that complement this approach, such as recognizing and overcoming barriers to adherence, ensuring optimal device use, and education and support to enhance patient–physician communication, are discussed. Physician education can also help raise awareness that additional management options are available for patients with moderate-to-severe asthma who remain uncontrolled on ICS/long-acting β2-agonist treatment.

show abstract

Section: Other Add-on Therapies For Adults With Asthma Uncontrolled Wmentioning

confidence: 99%

Section: Other Add-on Therapies For Adults With Asthma Uncontrolled Wmentioning

confidence: 99%

<p>Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies</p>

Jenkins

2019

TCRM

View full text Add to dashboard Cite

show abstract

Bronchial thermoplasty in a patient with difficult-to-control asthma

Cited by 1 publication

References 7 publications

<p>Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies</p>

<p>Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies</p>

Contact Info

Product

Resources

About